We are live on ! Find out more
KURA icon

Kura Oncology
KURA

133 hedge funds and large institutions have $687M invested in Kura Oncology in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 64 increasing their positions, 34 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 34

0.05% more ownership

Funds ownership: 101.41% → 101.46% (+0.05%)

10% less funds holding

Funds holding: 148 → 133 (-15)

14% less capital invested

Capital invested by funds: $795M → $687M (-$108M)

33% less funds holding in top 10

Funds holding in top 10: 6 → 4 (-2)

63% less first-time investments, than exits

New positions opened: 9 | Existing positions closed: 24

77% less call options, than puts

Call options by funds: $201K | Put options by funds: $892K

Holders
133
Holders Change
-15
Holders Change %
-10.14%
% of All Funds
2.11%
Holding in Top 10
4
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
9
Increased
64
Reduced
34
Closed
24
Calls
$201K
Puts
$892K
Net Calls
-$691K
Net Calls Change
-$6.23M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$11.5M
2
BlackRock
BlackRock
New York
+$7.75M
3
PM
Prosight Management
Texas
+$5.98M
4
SCM
Suvretta Capital Management
New York
+$3.12M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.79M

Top Sellers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
-$9.17M
2
Bank of America
Bank of America
North Carolina
-$7.42M
3
LGM
Logos Global Management
California
-$5.29M
4
Goldman Sachs
Goldman Sachs
New York
-$4.77M
5
EP
Eversept Partners
New York
-$4.77M
Name Holding Trade Value Shares
Change 		Change in
Stake
ACP
26
Acuta Capital Partners
California
$6.4M -$71.3K -7,025 -1%
CS
27
Candriam SCA
Luxembourg
$6.31M – – –
Charles Schwab
28
Charles Schwab
California
$5.14M +$875K +86,141 +18%
DCM
29
DAFNA Capital Management
California
$5.02M +$1.96M +193,000 +54%
JP Morgan Chase
30
JP Morgan Chase
New York
$4.39M -$209K -20,582 -4%
Goldman Sachs
31
Goldman Sachs
New York
$4.2M -$4.77M -469,561 -50%
AG
32
Algert Global
California
$3.33M +$1.81M +177,959 +95%
ACM
33
Alethea Capital Management
Washington
$3.2M +$173K +17,000 +5%
Walleye Capital
34
Walleye Capital
New York
$2.42M +$1.85M +182,221 +220%
Bank of New York Mellon
35
Bank of New York Mellon
New York
$2.39M +$261K +25,677 +11%
Rafferty Asset Management
36
Rafferty Asset Management
New York
$2.12M +$351K +34,574 +17%
D.E. Shaw & Co
37
D.E. Shaw & Co
New York
$1.89M -$51.2K -5,043 -2%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$1.79M +$543K +53,462 +38%
Millennium Management
39
Millennium Management
New York
$1.66M -$2.17M -213,741 -54%
Bank of America
40
Bank of America
North Carolina
$1.55M -$7.42M -730,792 -81%
Morgan Stanley
41
Morgan Stanley
New York
$1.47M -$1.29M -126,764 -44%
Barclays
42
Barclays
United Kingdom
$1.42M +$335K +32,978 +27%
Swiss National Bank
43
Swiss National Bank
Switzerland
$1.11M +$80.2K +7,900 +7%
Ensign Peak Advisors
44
Ensign Peak Advisors
Utah
$1.06M – – –
Renaissance Technologies
45
Renaissance Technologies
New York
$1.05M -$736K -72,500 -39%
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$1.01M +$53.4K +5,260 +5%
AQR Capital Management
47
AQR Capital Management
Connecticut
$1.01M +$982K +96,743 +696%
1CM
48
1492 Capital Management
Wisconsin
$916K – – –
Citigroup
49
Citigroup
New York
$899K +$227K +22,357 +29%
Susquehanna International Group
50
Susquehanna International Group
Pennsylvania
$833K -$33.7K -3,315 -4%
1
2
3 4 5

KURA Hedge Fund Activity: Q3 2023 in Review

133 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Kura Oncology (KURA) for Q3 2023, worth a combined $687M — down 14% from $795M a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of KURA and 9 opened new positions — a net loss of 15 holders — while 34 trimmed existing stakes and 64 added.

The largest buyer was Deerfield Management, adding an estimated $11.5M. The largest seller was Woodline Partners, exiting entirely with an estimated $9.17M sold.

  • 133 institutional investors held Kura Oncology (KURA) as of Q3 2023, down from 148 in Q2 2023.
  • Funds reported $687M of Kura Oncology stock for Q3 2023, down 14% quarter-over-quarter.
  • 9 funds opened new Kura Oncology positions in Q3 2023 and 24 closed out, a net change of -15 holders.
  • The largest Kura Oncology buyer in Q3 2023 was Deerfield Management, an estimated $11.5M added.
  • The largest Kura Oncology seller in Q3 2023 was Woodline Partners, an estimated $9.17M sold.

Based on aggregated 13F filings for Q3 2023.